Clinical Trial Details
— Status: Suspended
Administrative data
NCT number |
NCT05229666 |
Other study ID # |
8144 |
Secondary ID |
R01MD016278 |
Status |
Suspended |
Phase |
N/A
|
First received |
|
Last updated |
|
Start date |
December 9, 2021 |
Est. completion date |
November 2026 |
Study information
Verified date |
August 2023 |
Source |
Columbia University |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Interventional
|
Clinical Trial Summary
Pregnancy ends in preterm birth (PTB) for approximately 1 in 10 women, though more often for
Non-Hispanic Black women, 14.12% PTB rate, compared to 9.09% for Non-Hispanic White women.
Psychosocial stress and childhood trauma each are associated with risk for PTB and PTB has an
intergenerational impact: mothers born preterm are more likely to give birth pretern,
especially amongst Black women. In this project, we will study mitochondria, which contain
their own genome, the mitochondria DNA, and are inherited from the mother, as they represent
a potential intersection point between psychosocial experiences and their biological
embedding in underlying disease outcomes such as PTB
Description:
At odds with common assumptions - and hope, pregnancy ends in preterm birth (PTB) for
approximately 1 in 10 women. Yearly PTB affects 15 million infants worldwide and 386,580 in
the United States. PTB is the leading cause of global, and U.S., neonatal mortality and
morbidity and is associated with future risk for poor physical (higher blood pressure,
chronic kidney disease, wheeze/asthma) and mental (ADHD, IQ decrements) health. Maternal
health is not spared: women who deliver preterm are at an increased risk for depression,
hypertension, cardiovascular and renal disease later in life. In the U.S., the racial and
ethnic disparities in PTB rates are dramatic and independent of socio-economic status (SES):
overall, 14.12% for Non-Hispanic Black compared to 9.09% for Non-Hispanic White women.
Psychosocial stress and childhood trauma each are associated with risk for PTB. PTB has an
intergenerational impact: mothers born preterm are more likely to give birth pretern,
especially amongst Black women. Biomarkers to predict PTB have proven unsuccessful, and do
not account for this emerging recognition of intergenerational transmission of PTB risk
specifically via maternal heritage. Mitochondria, which contain their own genome, the
mitochondria DNA, are inherited from the mother and represent a potential intersection point
between psychosocial experiences and their biological embedding, including via immune
dysregulation, in underlying disease outcomes. We aim to apply a mitochondria psychobiology
approach to delineate by which mechanisms life stress - including discrimination and
childhood trauma - results in disproportionate risk of PTB in minority women, and evaluate
mitochondria as potential biomarkers of this birth outcome.
In a sample of post-attrition n=175 pregnant women we will test the following three aims: Aim
1: To determine whether a data driven approach to multiple, 1st trimester psychosocial (self-
report stress discrimination, 24-hour ambulatory mood, social support), lifecourse (hair
cortisol, childhood trauma), and biological variables (acute laboratory physiological stress
reactivity) generate unique stress profiles that partially explain the racial/ethnic
differences in gestational age at birth. Aim 2: To identify molecular indices of
mitochondrial and immune functioning in the mother (3x blood draw), placenta, and fetal cord
blood that mediate the association between 1st trimester maternal stress phenotypes and risk
for earlier gestational age at birth. Aim 3: To evaluate if reduction in stress levels and/or
improvement in social support over the course of pregnancy is associated with molecular
indices of mitochondrial and immune functioning and (exploratory) reduced risk of earlier
birth relative to national and hospital norms.
This new conceptual framing of this adverse health outcome (1) incorporates evidence of the
psychosocial factors contributing to risk, (2) aims to account for the racial/ethnic
disparities, and (3) harnesses cutting-edge mitochondria knowledge and tools to better
characterize PTB's pathophysiology and identify novel targets for its intervention and
prevention.